Core Lab Q2 rev $130.2M (+5% seq, flat YoY); ex-items EPS $0.19; free cash flow $10.4M

Core Laboratories Inc. /DE/

2025-Q2 EPS reported $0.22 vs consensus $0.19 ▲ beat (+15.4%)

Q2 revenue $130.2M (+5% sequentially, flat YoY); GAAP EPS $0.22; ex-items EPS $0.19 (-14% YoY, +33% sequentially).
Ex-items operating income $14.5M, margins 11% (+160 bps seq); incremental margins 41%.
Free cash flow $10.4M (+160% seq); net debt reduced $9.1M; leverage ratio improved to 1.27x.
Company repurchased 237,632 shares for $2.7M in Q2.
Credit facility amended: commitments raised to $150M from $135M, maturity extended to July 2029, $50M accordion.

item 1.01 item 2.02 item 2.03 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.